Here the authors report a randomized controlled trial to compare the effects of eTRF and mTRF in healthy volunteers without obesity, and find that eTRF is more effective in improving the primary outcome insulin sensitivity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.